On June 26, 2025, Medirom Healthcare Technologies Inc. announced the approval of a new stock option allotment under its 2024 Equity Incentive Compensation Plan. The approved issuance includes 207,000 stock options for directors and statutory auditors, 87,000 for company employees, and 106,000 for external collaborators. These stock options are contingent upon the company's adjusted consolidated revenues surpassing JPY10 billion in any fiscal year between 2026 and 2028, excluding revenues from Digital Preventative Healthcare and Sales of Directly-Owned Salons. Additionally, holders must remain affiliated with Medirom or its subsidiaries to exercise their options, with certain exceptions for tenure expiration or retirement. The company anticipates recipients to formalize stock option agreements by July 7, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.